May Health

May Health, a medical device company focused on expanding treatment options for women living with polycystic ovary syndrome (PCOS), announced that it has raised €10 million (about $11.7 million) in new funding. The round included participation from existi

May Health, a medical device company dedicated to helping women living with polycystic ovary syndrome (PCOS), today announced that it raised €10 million ($11...

May Health Announces CE Mark for Innovative Treatment for Women with PCOS-related Infertility

May Health, a Paris- and California-based, clinical-stage medical device company dedicated to the development of a new treatment for Polycystic Ovary Syndrome (PCOS), today announced that Colby Holtshouse has joined the Company as President and CEO. Colby

/PRNewswire/ -- May Health, a Paris- and California-based, clinical-stage medical device company dedicated to the development of a new treatment for Polycystic...

May Health, a clinical-stage medical device company dedicated to helping those living with the endocrine disorder polycystic ovary syndrome (PCOS), announced it has closed a $25 million Series B financing round, co-led by Bpifrance and Trill Impact with p

May Health Raises 25 Million in Series B Funding to Advance Development for Ovarian Rebalancing Therapy

May Health Announces Data From Feasibility Studies of its Novel Ovarian Rebalancing Treatment and Receives Approval From FDA for Pivotal Trial

May Health Solidifies Veteran Executive Team with Appointment of Womens Health Care Leader Anne Morrissey as CEO